Novo Nordisk crossroads: Can the pharma giant address the supply dilemma?
Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market…
Sanofi cuts price of insulin Lantus, following Eli Lilly, Novo Nordisk
Amid consumer angst and political pressure over the cost of life-saving insulin, Sanofi announced Thursday it would slash the price of its most-prescribed insulin, Lantus. Sanofi…